Castells-Nobau, A.* et al. Multiomics of the intestine-liver-adipose axis in multiple studies unveils a consistent link of the gut microbiota and the antiviral response with systemic glucose metabolism. Gut, DOI: 10.1136/gutjnl-2024-332602 (2024)
Vogt, M.A.* et al. Targeting MYC effector functions in pancreatic cancer by inhibiting the ATPase RUVBL1/2. Gut, DOI: 10.1136/gutjnl-2023-331519 (2024)
Akhlaghpour, M.* et al. Genetic coding variant in complement factor B (CFB) is associated with increased risk for perianal Crohn's disease and leads to impaired CFB cleavage and phagocytosis. Gut 72, 2068-2080 (2023)
Luo, S. et al. Helicobacter pylori infection alters gut virome by expanding temperate phages linked to increased risk of colorectal cancer. Gut, DOI: 10.1136/gutjnl-2023-330362 (2023)
Ralser, A.* et al. Helicobacter pylori promotes colorectal carcinogenesis by deregulating intestinal immunity and inducing a mucus-degrading microbiota signature. Gut 72, 1258-1270 (2023)
Belda, E.* et al. Impairment of gut microbial biotin metabolism and host biotin status in severe obesity: Effect of biotin and prebiotic supplementation on improved metabolism. Gut 71, 2463-2480 (2022)
Onogi, Y. & Ussar, S. Is epiploic fat the dermal fat of the intestine? Gut 71, 2147-2148 (2022)
Krieg, L.* et al. Multiomics reveal unique signatures of human epiploic adipose tissue related to systemic insulin resistance. Gut, DOI: 10.1136/gutjnl-2021-324603 (2021)
Thangapandi, V.R.* et al. Loss of hepatic Mboat7 leads to liver fibrosis. Gut 70, 940-950 (2021)
Khaloian, S.* et al. Mitochondrial impairment drives intestinal stem cell transition into dysfunctional Paneth cells predicting Crohn's disease recurrence. Gut 69, 1939-1951 (2020)
Massier, L.* ; Chakaroun, R.* ; Kovacs, P.* & Heiker, J.T. Blurring the picture in leaky gut research: How shortcomings of zonulin as a biomarker mislead the field of intestinal permeability. Gut 70, 1801-1802 (2020)
Tjalma, J.J.J.* et al. Quantitative fluorescence endoscopy: An innovative endoscopy approach to evaluate neoadjuvant treatment response in locally advanced rectal cancer. Gut 69, 406-410 (2020)
Lindfors, K.* et al. Metagenomics of the faecal virome indicate a cumulative effect of enterovirus and gluten amount on the risk of coeliac disease autoimmunity in genetically at risk children: The TEDDY study. Gut 69, 1416–1422 (2019)
Nagengast, W.B.* et al. Near-infrared fluorescence molecular endoscopy detects dysplastic oesophageal lesions using topical and systemic tracer of vascular endothelial growth factor A. Gut 68, 7-10 (2019)
Rosendahl, J.* et al. Genome-wide association study identifies inversion in the CTRB1-CTRB2 locus to modify risk for alcoholic and non-alcoholic chronic pancreatitis. Gut 67, 1855–186 (2018)
Hanin, G.* et al. miRNA-132 induces hepatic steatosis and hyperlipidaemia by synergistic multitarget suppression. Gut 67, 1124-1134 (2017)
Seleznik, G.M.* et al. Development of autoimmune pancreatitis is independent of CDKN1A/p21-mediated pancreatic inflammation. Gut 67, 1663-1673 (2017)
Sommer, F.* et al. Microbiomarkers in inflammatory bowel diseases: Caveats come with caviar. Gut 66, 1734-1738 (2017)
Kirsten, H.* et al. Genetic variants of lipase activity in chronic pancreatitis. Gut 65, 184-185 (2016)
Kong, B.* et al. A subset of metastatic pancreatic ductal adenocarcinomas depends quantitatively on oncogenic Kras/Mek/Erk-induced hyperactive mTOR signalling. Gut 65, 647-657 (2016)
Kong, B.* et al. Dynamic landscape of pancreatic carcinogenesis reveals early molecular networks of malignancy. Gut 67, 146-156 (2016)
Lee, T.* et al. Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD. Gut 66, 863-871 (2016)
Mejías-Luque, R.* et al. Lymphotoxin β receptor signalling executes Helicobacter pylori-driven gastric inflammation in a T4SS-dependent manner. Gut 66, 1369-1381 (2016)
Sautto, G.A.* et al. Chimeric Antigen Receptor (CAR)-engineered T cells redirected against Hepatitis C Virus (HCV) E2 glycoprotein. Gut 65, 512-523 (2016)
Derikx, M.H.* et al. Polymorphisms at PRSS1-PRSS2 and CLDN2-MORC4 loci associate with alcoholic and non-alcoholic chronic pancreatitis in a European replication study. Gut 64, 1426-1433 (2015)
Garnelo, M.* et al. Interaction between tumour-infiltrating B cells and T cells controls the progression of hepatocellular carcinoma. Gut 66, 342-351 (2015)
Habegger, K.M.* et al. Duodenal nutrient exclusion improves metabolic syndrome and stimulates villus hyperplasia. Gut 63, 1238-1246 (2014)
Chew, V.* et al. Chemokine-driven lymphocyte infiltration: An early intratumoural event determining long-term survival in resectable hepatocellular carcinoma. Gut 61, 427-438 (2012)
Fritsche, P.* et al. HDAC2 mediates therapeutic resistance of pancreatic cancer cells via the BH3-only protein NOXA. Gut 58, 1399-1409 (2009)
Koletzko, S.* et al. Rectal biopsy for diagnosis of intestinal neuronal dysplasia in children: A prospective multicentre sstudy on interobserver variation and clinical outcome. Gut 44, 853-861 (1999)